These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis. Reich K, Gessner C, Kroker A, Schwab JA, Pohl W, Villesen H, Wüstenberg E, Emminger W. Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092 [Abstract] [Full Text] [Related]
27. [Effect of posterior nasal neurectomy combined with the inferior turbinate surgery for Japanese cedar pollinosis]. Kamijo A, Kuroda Y, Hatsushika K, Nakajima M, Yamamoto T, Moriyama M, Okamoto A, Kase Y, Masuyama K. Arerugi; 2013 May; 62(5):560-5. PubMed ID: 23760201 [Abstract] [Full Text] [Related]
29. Alleviation of seasonal allergic symptoms with superfine beta-1,3-glucan: a randomized study. Yamada J, Hamuro J, Hatanaka H, Hamabata K, Kinoshita S. J Allergy Clin Immunol; 2007 May; 119(5):1119-26. PubMed ID: 17379290 [Abstract] [Full Text] [Related]
30. Re-treatment with omalizumab at one year interval for Japanese cedar pollen-induced seasonal allergic rhinitis is effective and well tolerated. Ogino S, Nagakura T, Okubo K, Sato N, Takahashi M, Ishikawa T. Int Arch Allergy Immunol; 2009 May; 149(3):239-45. PubMed ID: 19218816 [Abstract] [Full Text] [Related]
31. High contribution contrast between the genes of eosinophil peroxidase and IL-4 receptor alpha-chain in Japanese cedar pollinosis. Nakamura H, Miyagawa K, Ogino K, Endo T, Imai T, Ozasa K, Motohashi Y, Matsuzaki I, Sasahara S, Hatta K, Eboshida A. J Allergy Clin Immunol; 2003 Dec; 112(6):1127-31. PubMed ID: 14657871 [Abstract] [Full Text] [Related]
32. Changes in plasma TARC levels during Japanese cedar pollen season and relationships with symptom development. Xiao JZ, Kondo S, Takahashi N, Odamaki T, Iwabuchi N, Miyaji K, Iwatsuki K, Enomoto T. Int Arch Allergy Immunol; 2007 Dec; 144(2):123-7. PubMed ID: 17536220 [Abstract] [Full Text] [Related]
34. Effects of polysaccharide derived from black currant on relieving clinical symptoms of Japanese cedar pollinosis: a randomized double-blind, placebo-controlled trial. Dejima K, Ohshima A, Yanai T, Yamamoto R, Takata R, Yoshikawa T. Biosci Biotechnol Biochem; 2007 Dec; 71(12):3019-25. PubMed ID: 18071252 [Abstract] [Full Text] [Related]
35. [Japanese cedar pollinosis is a risk factor for bronchial asthma in Japanese adult asthmatics]. Ueno K, Minoguchi K, Kohno Y, Oda N, Wada K, Miyamoto M, Yokoe T, Hashimoto T, Minoguchi H, Miyamoto M, Yokoe T, Hashimoto T, Minoguchi H, Tanaka A, Kokubu F, Adachi M. Arerugi; 2002 Jul; 51(7):565-70. PubMed ID: 12201170 [Abstract] [Full Text] [Related]
36. Leuconostoc mesenteroides subsp. strain NTM048 ameliorated nasal symptoms in patients with Japan cedar pollinosis: Randomized, double-blind, and placebo-controlled trial. Yamamoto Y, Sugita G, Hiraoka M, Takagi S, Yamagishi N, Kawashima S, Tanioka K, Nishi T, Yamamoto S, Kakutani C, Yanase A, Kanai Y, Kato S, Hotomi M. Medicine (Baltimore); 2023 Nov 10; 102(45):e35343. PubMed ID: 37960817 [Abstract] [Full Text] [Related]
39. Phase I/II study of oral immunotherapy with Cry j1-galactomannan conjugate for Japanese cedar pollinosis. Murakami D, Kubo K, Sawatsubashi M, Kikkawa S, Ejima M, Saito A, Kato A, Komune S. Auris Nasus Larynx; 2014 Aug 10; 41(4):350-8. PubMed ID: 24698163 [Abstract] [Full Text] [Related]